Clinical Trial Update: The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study

View source ↗

Summary

This clinical study assesses whether artificial intelligence-enhanced 18F-FDG PET/CT can aid differential diagnosis, predict treatment efficacy, and forecast pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Natural Killer T-cell Lymphoma

Snippet

Sponsor: Ruijin Hospital | Conditions: T-NK Cell Lymphoma | Status: NOT_YET_RECRUITING